Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: ODTX) Delayed: 24.38 +1.16 (5.00%)
Previous Close $23.22    52 Week High
Open $23.35    52 Week Low
Day High $25.15    P/E N/A 
Day Low $22.88    EPS
Volume 2,604,396